Microenvironmental control of malignancy exerted by RNASET2, a widely conserved extracellular RNase

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 3, 2011, Pages 1104-1109

  Acquati, Francesco ^a   Bertilaccio, Sabrina ^b   Grimaldi, Annalisa ^a   Monti, Laura ^a   Cinquetti, Raffaella ^a   Bonetti, Paolo ^a   Lualdi, Marta ^a   Vidalino, Laura ^c   Fabbri, Marco ^d   Sacco, Maria Grazia ^d   Van Rooijen, Nico ^e   Campomenosi, Paola ^a   Vigetti, Davide ^a   Passi, Alberto ^a   Riva, Cristina ^f   Capella, Carlo ^f   Sanvito, Francesca ^b   Doglioni, Claudio ^b   Gribaldo, Laura ^d   Macchi, Paolo ^c   Sica, Antonio ^g,h   Noonan, Douglas M ^a   Ghia, Paolo ^b   Taramelli, Roberto ^a   more..

^a UNIVERSITY OF INSUBRIA   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF TRENTO   (Italy)

^d JOINT RESEARCH CENTRE   (Italy)

^e VU UNIVERSITY AMSTERDAM   (Netherlands)

^f OSPEDALE DI CIRCOLO   (Italy)

^g HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^h UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Ovarian cancer; Xenograft cancer model

Indexed keywords

RIBONUCLEASE; RIBONUCLEASE T2; UNCLASSIFIED DRUG;

ARTICLE; CANCER CONTROL; CARCINOGENESIS; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE ACTIVITY; GENETIC CODE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOMA; OVARY CARCINOMA; OVARY TUMOR; PRIORITY JOURNAL; TUMOR MICROENVIRONMENT; TUMOR SUPPRESSOR GENE;

ANALYSIS OF VARIANCE; ANIMALS; CELL LINE, TUMOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MACROPHAGES; MICE; MICE, NUDE; OVARIAN NEOPLASMS; RIBONUCLEASES; TUMOR SUPPRESSOR PROTEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79551627864     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1013746108     Document Type: Article

References (38)

1. Runnebaum IB, Stickeler E (2001) Epidemiological and molecular aspects of ovarian cancer risk. J Cancer Res Clin Oncol 127(2):73-79.
2. McGuire WP, 3rd (2003) Current status of taxane and platinum-based chemotherapy in ovarian cancer. J Clin Oncol 21(10, Suppl):133s-135s.
3. Feeley KM, Wells M (2001) Precursor lesions of ovarian epithelial malignancy. Histopathology 38(2):87-95.
4. Shih IeM, Kurman RJ (2004) Ovarian tumorigenesis: A proposed model based on morphological and molecular genetic analysis. Am J Pathol 164:1511-1518.
5. Auersperg N, Maines-Bandiera SL, Dyck HG, Kruk PA (1994) Characterization of cultured human ovarian surface epithelial cells: Phenotypic plasticity and premalignant changes. Lab Invest 71:510-518. (Pubitemid 24338158)
6. Murdoch WJ, McDonnel AC (2002) Roles of the ovarian surface epithelium in ovulation and carcinogenesis. Reproduction 123:743-750. (Pubitemid 34662050)
7. Mueller MM, Fusenig NE (2004) Friends or foes - Bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4:839-849.
8. Liotta LA, Kohn EC (2001) The microenvironment of the tumour-host interface. Nature 411:375-379.
9. Klein G, Imreh S, Zabarovsky ER (2007) Why do we not all die of cancer at an early age? Adv Cancer Res 98:1-16.
10. Klein G (2001) Are there large uncharted regions of tumor suppressor genes? IUBMB Life 51(2):83-85.
11. Imreh S, Klein G, Zabarovsky ER (2003) Search for unknown tumor-antagonizing genes. Genes Chromosomes Cancer 38:307-321.
12. Klein G (2009) Toward a genetics of cancer resistance. Proc Natl Acad Sci USA 106: 859-863.
13. Harris H, Miller OJ, Klein G, Worst P, Tachibana T (1969) Suppression of malignancy by cell fusion. Nature 223:363-368.
14. Trubia M, Sessa L, Taramelli R (1997) Mammalian Rh/T2/S-glycoprotein ribonuclease family genes: Cloning of a human member located in a region of chromosome 6 (6q27) frequently deleted in human malignancies. Genomics 42:342-344.
15. Acquati F, et al. (2001) Cloning and characterization of a senescence inducing and class II tumor suppressor gene in ovarian carcinoma at chromosome region 6q27. Oncogene 20:980-988.
16. Acquati F, et al. (2005) Tumor and metastasis suppression by the human RNASET2 gene. Int J Oncol 26:1159-1168.
17. Monti L, et al. (2008) RNASET2 as a tumor antagonizing gene in a melanoma cancer model. Oncol Res 17(2):69-74.
18. Steinemann D, et al. (2003) Identification of candidate tumor-suppressor genes in 6q27 by combined deletion mapping and electronic expression profiling in lymphoid neoplasms. Genes Chromosomes Cancer 37:421-426.
19. Kim TY, Zhong S, Fields CR, Kim JH, Robertson KD (2006) Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma. Cancer Res 66:7490-7501. (Pubitemid 44289203)
20. Morita R, et al. (1991) Common regions of deletion on chromosomes 5q, 6q, and 10q in renal cell carcinoma. Cancer Res 51:5817-5820.
21. Tibiletti MG, et al. (1996) Early involvement of 6q in surface epithelial ovarian tumors. Cancer Res 56:4493-4498. (Pubitemid 26330460)
22. Theile M, et al. (1996) A defined chromosome 6q fragment (at D6S310) harbors a putative tumor suppressor gene for breast cancer. Oncogene 13:677-685.
23. Hauptschein RS, et al. (1998) Cloning and mapping of human chromosome 6q26-q27 deleted in B-cell non-Hodgkin lymphoma and multiple tumor types. Genomics 50(2): 170-186.
24. Sica A, et al. (2008) Macrophage polarization in tumour progression. Semin Cancer Biol 18:349-355.
25. Luhtala N, Parker R (2010) T2 Family ribonucleases: Ancient enzymes with diverse roles. Trends Biochem Sci 35:253-259.
26. Liu Y, et al. (2002) Physical and transcript map of the region between D6S264 and D6S149 on chromosome 6q27, the minimal region of allele loss in sporadic epithelial ovarian cancer. Oncogene 21:387-399.
27. Smirnoff P, Roiz L, Angelkovitch B, Schwartz B, Shoseyov O (2006) A recombinant human RNASET2 glycoprotein with antitumorigenic and angiogenic characteristics. Cancer 107:2760-2769.
28. Wang F, et al. (2008) HYAL1 and HYAL2 inhibit tumour growth in vivo but not in vitro. PLoS ONE 3:e3031.
29. Sharp TV, et al. (2004) LIM domains-containing protein 1 (LIMD1), a tumor suppressor encoded at chromosome 3p21.3, binds pRB and represses E2F-driven transcription. Proc Natl Acad Sci USA 101:16531-16536.
30. Yang L, et al. (2005) Tumor suppressive role of a 2.4 Mb 9q33-q34 critical region and DEC1 in esophageal squamous cell carcinoma. Oncogene 24:697-705.
31. Gourley C, et al. (2009) WWOX gene expression abolishes ovarian cancer tumorigenicity in vivo and decreases attachment to fibronectin via integrin alpha3. Cancer Res 69:4835-4842.
32. Steinfelder S, et al. (2009) The major component in schistosome eggs responsible for conditioning dendritic cells for Th2 polarization is a T2 ribonuclease (omega-1). J Exp Med 206:1681-1690.
33. Henneke M, et al. (2009) RNASET2-deficient cystic leukoencephalopathy resembles congenital cytomegalovirus brain infection. Nat Genet 41:773-775.
34. Thompson DM, Parker R (2009) The RNase Rny1p cleaves tRNAs and promotes cell death during oxidative stress in Saccharomyces cerevisiae. J Cell Biol 185(1):43-50.
35. Thompson DM, Lu C, Green PJ, Parker R (2008) tRNA cleavage is a conserved response to oxidative stress in eukaryotes. RNA 14:2095-2103.
36. Thompson DM, Parker R (2009) Stressing out over tRNA cleavage. Cell 138:215-219.
37. McNally AK, Chisolm GM, Morel DW, Cathcart MK (1990) Activated human monocytes oxidize LDL by a lipoxygenase-dependent pathway. J Immunol 145:254-259.
38. Sunderkötter C, et al. (2004) Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J Immunol 172:4410-4417.